The report is a complex analysis of OTC drug and dietary supplement markets in eight countries in the region:
Russia
Poland
Ukraine
Romania
the Czech Republic
Hungary
Bulgaria
Slovakia.
It analyses the market value in particular countries, as well as in the whole
CEE region and pays particular attention to such information as OTC drug
market value, dietary supplement market value, share of OTC in the total
market, best-selling OTC products, leading OTC manufacturers, and
non-pharmacy and online sales of OTC products.
The publication also contains forecasts up to 2013 for OTC drug/product
markets in particular countries as well as for the whole region, prepared
by a team of pharmaceutical market analysts and PMR's economy experts. The
report is complemented with the analysis of distribution segments in
particular countries. It is a unique publication which presents all the
important information regarding the OTC product market in the CEE region on
more than 300 pages.
Key topics covered:
best selling OTC drugs in individual countries
best selling dietary supplements in individual countries
leading OTC drug manufacturers in individual countries
profiles of leading regional OTC manufacturers
leading dietary supplement manufacturers in individual countries
OTC drug market value 2007-2013 in individual countries
dietary supplements market value in individual countries
share of OTC in total pharmacy sales in individual countries
sales structure of OTC products in pharmacy sales in individual countries
regulations regarding non-pharmacy sales of OTC products in individual
countries
regulations regarding online sales of OTC products in individual countries
largest advertisers in the OTC segment in individual countries
largest pharmacy chains in individual countries
largest wholesalers in individual countries
main events and trends in individual countries
comparative analysis of OTC market value, share of OTC as a proportion of
the entire market and share of dietary supplements as a proportion of the
entire market
consumer behaviours regarding OTC product intake in individual countries
epidemiological trends.
When will the report prove useful?
when starting a business on the OTCmarket in CEE
when developing OTC products sales in CEE
when analysing competitors
when analysing the market saturation
when developing OTC products portfolio in a particular CEE country.
Report strengths:
all information regarding the OTC products segment in CEE in one place
comparative analysis of OTC product markets in 8 countries
the report provides broad range of historical data as it is its third
edition
development forecasts for 2011-2013.
Find answers for the following questions:
In which country is the OTC market the largest?
In which country has the OTC market the highest growth potential?
Which CEE country has the " friendliest" environment for OTC products?
In which country is the OTC market profoundly saturated?
What are the strategies OTC manufacturers introduce into the market in CEE?
This report is adressed to:
the senior management of OTC companies active in the region
According to our forecasts, in the next three years the most attractive of
the analysed markets in the region, taking into account forecasted market
growth, will be Bulgaria.
According to our forecasts, in 2011 the OTC market in Central and Eastern
Europe will grow by close to 10% in real terms. In 2012 it will see a positive
growth rate of more than 9%, whereas in 2013 it will expand by around 8%.
Market commentary by expert
According to our estimates, in 2010 the OTC market in the CEE region was worth
some € 10.7bn, which represented an increase of approx. 13% y-o-y in euro
terms. A half was generated by Russia. In 2010, Poland was the second largest
OTC market in the region, with a share in total sales of around 23%. Ukraine
accounted for around 7% of all OTC business on the CEE market. According to
our forecasts, between 2011 and 2013 the market will expand by around 9% on
average per annum. Bulgaria and Ukraine will be the fastest developing markets
in the region in the analysed period. Agnieszka Skonieczna,
Pharmaceutical Market Analyst
Table of Contents
Table of Contents
I.Report methodology
II.Executive summary
III.OTC market in CEE countries
Comparative analysis of OTC markets in CEE region
Share of individual OTC markets in 2010
Per capita OTC spending in CEE countries
Value of OTC market in CEE countries 2008-2013
Average CAGR for OTC markets in CEE countries 2009-2010 and 2011-2013
Russia
Main trends and events on OTC market
OTC market value
OTC market value by distribution channel
OTC market value by product status (drugs vs. dietary supplements)
Share of OTC as a proportion of the pharmaceutical market
Value of OTC drug market between 2008 and 2013
Value of dietary supplement market between 2008 and 2013
OTC product market by therapeutic category
Prices of OTC products
Best-selling OTC products
Poland
Main trends and events on OTC market
OTC market value
OTC market value by distribution channel
OTC market value by product status (drugs vs. dietary supplements)
Share of OTC as a proportion of the pharmaceutical market
Value of OTC product market between 2008 and 2013
Value of dietary supplement market
OTC products market by therapeutic category
Prices of OTC products
Switch from Rx to OTC
Best-selling OTC products
Ukraine
Main trends and events on OTC market
OTC market value
OTC market value by product status (drugs vs. dietary supplements)
Share of OTC as a proportion of the pharmaceutical market
Value of OTC drug market between 2008 and 2013
Value of dietary supplement market between 2008 and 2013
Prices of OTC products
Switch from Rx to OTC
Best-selling OTC products
Czech Republic
Main trends and events on OTC market
OTC market value
OTC market value by distribution channel
OTC drug market by volume
Share of OTC as a proportion of the pharmaceutical market
Value of OTC product market between 2008 and 2013
Value of dietary supplement market
OTC product market by therapeutic category
Prices of OTC products
Switch from Rx to OTC
Best-selling OTC products
Romania
Main trends and events on OTC market
OTC market value
OTC market value by distribution channel
OTC market value by product status (drugs vs. dietary supplements)
Share of OTC as a proportion of the pharmaceutical market
Value of OTC product market between 2006 and 2013
Value of dietary supplement market between 2005 and 2013
OTC drug market by therapeutic category
Prices of OTC products
Switch from Rx to OTC
Best-selling OTC products
Hungary
Main trends and events on OTC market
OTC market value
OTC market value by distribution channel
OTC market value by product status (drugs vs. dietary supplements)
Share of OTC as a proportion of the pharmaceutical market
Value of OTC product market between 2008 and 2013
Value of dietary supplement market
OTC drug market by therapeutic category
Prices of OTC products
Switch from Rx to OTC
Best-selling OTC products
Bulgaria
Main trends and events on OTC market
OTC market value
OTC market value by distribution channel
OTC market value by product status (drugs vs. dietary supplements)
Share of OTC as a proportion of the pharmaceutical market
Value of OTC product market between 2009 and 2013
Value of dietary supplement market
OTC drug market by therapeutic categories
Prices of OTC products
Best-selling OTC products
Slovakia
Main trends and events on OTC market
OTC market value
OTC market value by distribution channel
Share of OTC as a proportion of the pharmaceutical market
Value of OTC product market between 2006 and 2012
OTC drug market by therapeutic category
Prices of OTC products
Switch from Rx to OTC
Best-selling OTC products
IV.Advertising of OTC products in CEE countries
Russia
Legal framework
Spending on OTC advertising
Poland
Legal framework
Spending on OTC advertising
TV advertising
Radio advertising
Internet advertising
Outdoor advertising
Ukraine
Legal framework
Spending on OTC advertising
TV advertising
Radio advertising
Press advertising
Internet advertising
Czech Republic
Legal framework
Spending on OTC advertising
TV advertising
Radio advertising
Press advertising
Advertising on other media
Romania
Legal framework
Spending on OTC advertising
Hungary
Legal framework
Spending on OTC advertising
Bulgaria p. 158
Legal framework
Spending on OTC advertising
Slovakia p. 159
Legal framework
Spending on OTC advertising
V.Key manufacturers
Profiles of selected local manufacturers on OTC market in CEE
Key players in selected CEE countries
Russia
Poland1
Ukraine
Czech Republic
Romania
Hungary
Bulgaria
Slovakia
VI.Distribution
Russia
Pharmaceutical wholesalers
Segment profile
Selected key players
Pharmacy distribution
Segment profile
Selected key players
Non-pharmacy sales
Online sales
Poland
Pharmaceutical wholesalers
Segment profile
Selected key players
Pharmacy distribution
Segment profile
Selected key players
Non-pharmacy sales
Online sales
Ukraine
Pharmaceutical wholesalers
Segment profile
Selected key players
Pharmacy distribution
Segment profile
Selected key players p
Non-pharmacy sales
Online sales
Czech Republic
Pharmaceutical wholesalers
Segment profile
Selected key players
Pharmacy distribution
Segment profile
Selected key players
Non-pharmacy sales
Online sales
Romania
Pharmaceutical wholesalers
Segment profile
Selected key players
Pharmacy distribution
Segment profile
Selected key players
Non-pharmacy sales
Online sales
Hungary
Pharmaceutical wholesalers
Segment profile
Selected key players
Pharmacy distribution
Segment profile
Selected key players
Non-pharmacy sales
Online sales
Bulgaria
Pharmaceutical wholesalers
Segment profile
Selected key players
Pharmacy distribution
Segment profile
Selected key players
Non-pharmacy sales
Online sales
Slovakia
Pharmaceutical wholesalers
Segment profile
Selected key players
Pharmacy distribution
Segment profile
Selected key players
Non-pharmacy sales
Online sales p. 307
Comparative analysis of distribution in CEE
Non-pharmacy sales
Online sales
Pharmacy distribution
VII.Factors influencing OTC market in CEE countries
Macroeconomic and demographic indicators
GDP growth
Inflation rates
Labour market
Unemployment rates
Wage levels
Population
Epidemiological trends
Life expectancy at birth
Weight problems
Alcohol consumption
Smoking prevalence
VIII.List of graphs
IX.List of tables
X.About PMR
List of graphs
1.Share of individual OTC markets as a proportion of total OTC market in
CEE, 2010
2.Value (€ bn) and y-o-y change of the OTC products market in CEE,
2008-2013
3.Share of individual OTC markets as a proportion of total OTC market in
CEE, 2010
4.Per capita spending on OTC products (€ ) in CEE countries, 2010
5.Per capita spending on dietary supplements (€ ) in CEE countries,
2010
6.Value (€ bn) and y-o-y change of the OTC products market in CEE,
2008-2013
7.Average CAGR for OTC markets in the analysed CEE countries for years
2009-2010
8.Average CAGR for OTC markets in the analysed CEE countries for years
2011-2013
9.Market share of drugs and dietary supplements as a proportion of the
out-of-the-pocket pharmacy market for plant-based liver protector products in
Russia, by value and volume, Q1-Q3 2010
10.Pharmacy sales of OTC products in Russia, by product status, 2010
11.Total sales of OTC products in Russia, by product status, 2010
12.Share of OTC drugs as a proportion of the Russian pharmaceutical
market, by value, 2010
13.Share of OTC drugs as a proportion of the Russian out-of-the-pocket
market, by value and volume, 2008-2010
14.Share of OTC drugs as a proportion of Russian drug imports, by value
and volume, 2009 and 2010 32
15.Share of OTC drugs as a proportion of the Russian generic drug market,
by value, 2008-2010
16.Value (RUB bn) and y-o-y change in the OTC drug market in Russia,
2008-2013
17.Value (RUB bn) and y-o-y change in the dietary supplement market in
Russia, 2008-2013
18.OTC drug market in Russia, by main product categories (€ m), 2010
19.Dietary supplement pharmacy market in Russia, by main product
categories (€ m), 2010
20.Market share of main dietary supplement categories in Russia, by value,
2010
21.Average prices of OTC drugs per package in Russia ($), 2002-Q1 2011
22.Average prices of dietary supplements per package in Russia ($),
2008-Q1 2011
23.Price ranges of dietary supplements in Russia, by value, imported and
domestic, 2010
24.Market share of top 10 best selling OTC drugs in Russia, by sales
value, 2010
25.Sales value of top 10 best selling dietary supplements in Russia
(€ m), 2010
26.Market share of top 10 best selling dietary supplements in Russia, by
sales value, 2010
27.Value of Polish dermocosmetics market (PLN m) and y-o-y change,
2008-2011
28.OTC product market in Poland, by sales channel, 2010
29.Pharmacy sales of OTC products in Poland, by product status, 2010
30.Non-pharmacy sales of OTC products in Poland, by product status, 2010
49
31.OTC drugs market in Poland, by sales channel, 2010
32.Total sales of OTC products in Poland, by product status, 2010
33.Share of OTC drugs as a proportion of the Polish pharmaceutical market,
by value, 2010
34.Value (PLN bn) and y-o-y change in the OTC product market in Poland,
2008-2013
35.Value (PLN m) and y-o-y change in the dietary supplement market in
Poland, 2005-2012
36.OTC product market in Poland, by main product categories (€ m),
2010
37.The most popular categories of OTC products in Poland, 2010
38.Value shares of individual therapeutic categories in the non-pharmacy
market of medicines in Poland, 2010
39.Shares of individual therapeutic categories of medicines in the number
of products in hypermarkets in Poland, 2011
40.Shares of individual therapeutic categories of dietary supplements in
the number of products in hypermarkets in Poland, 2011
41.Price per package and pharmacy margins imposed on OTC products in
Poland, 2008-2010
42.Average prices of OTC products per package (PLN) and y-o-y change in
Poland, 2002-H1 2011
43.The number of Rx-OTC status changes in Poland, 2008-2010
44.Best-selling product categories available from online pharmacies in
Poland, 2010
45.Percentage of OTC and Rx prescriptions in Ukraine, by doctor's
specialisation, November 2010
46.Share of individual ATC categories as a proportion of the list of OTC
drugs approved in Ukraine, by number of items, December 2010
47.Factors which influence drug purchases at pharmacies in Ukraine, 2011
48.Frequency of OTC drug purchases in Ukraine, 2011
49.Pharmacy sales of OTC products in Ukraine, by product category (UAH m),
2007-2010
50.Pharmacy sales of OTC products in Ukraine, by product category ($ m),
2007-2010
51.Pharmacy OTC product market in Ukraine ($ m), by quarter, and y-o-y
increase, Q1 2009-Q4 2010
52.Pharmacy sales of OTC products in Ukraine, by product category (m
packages), 2007-2010
53.Year-on-year change in OTC drug and dietary supplement value and volume
in Ukraine, in comparison with other product categories, H1 2011
54.Share of OTC drugs as a proportion of the Ukrainian pharmaceutical
market, by value, 2010
55.Value (UAH m) and y-o-y change in the OTC drug market in Ukraine,
2008-2013
56.Value of dietary supplement pharmacy sales in Ukraine (UAH m), by
foreign and domestic products, 2008-2010
57.Volume of dietary supplement pharmacy sales in Ukraine (m packages), by
foreign and domestic products, 2008-2010
58.Value (UAH m) and y-o-y change in the dietary supplement market in
Ukraine, 2008-2013
59.Average prices of OTC drugs per package in Ukraine ($), 2007-2010
60.Average prices of cosmetics per package in Ukraine ($), 2007-2010
61.Average prices of dietary supplements per package in Ukraine ($),
2007-2010
62.Factors which influence OTC drug purchases in the Czech Republic, 2011
63.Overweight and obesity of adults in the Czech Republic (% of total
population), 2000, 2005, 2008 and 2010
64.Number of OTC drug packages sold in the Czech Republic (million),
2006-Q1 2011
65.Share of OTC products as a proportion of the Czech pharmaceutical
market, by value, 2010
66.Value (CZK bn) and y-o-y change the OTC product market in the Czech
Republic, 2008-2013
67.OTC product market in the Czech Republic, by main product categories
(€ m), 2010
68.Boehringer Ingelheim sales revenues by product groups in Romania (RON
m), 2009 and 2010
69.Antibiotice Iasi financial results (RON m), H1 2010 and H1 2011
70.Pharmacy sales of OTC products in Romania, by product status, 2010
93
71.Share of OTC products as a proportion of the Romanian pharmaceutical
market, by value, 2010
72.Value (RON m) and y-o-y change in the OTC products market in Romania,
2006-2013
73.Value (RON m) and y-o-y change in the dietary supplement market in
Romania, 2005-2013
74.OTC drug market in Romania, by main product categories (€ m),
2010
75.Opinions about OTC drugs in Hungary (%), 2009
76.Opinions about dietary supplements in Hungary (%), 2009
77.Influence of particular types of advertisements on Hungarians' drug
purchases, Q3 2010
78.Influence of particular types of advertisements on Hungarians' health
and beauty products purchases, Q3 2010
79.Knowledge of expression " functional/curative food" in Hungary,
January 2011
80.OTC product market in Hungary, by sales channel, 2010
81.Pharmacy sales of OTC products in Hungary, by product status, 2010
82.Non-pharmacy sales of OTC products in Hungary, by product status, 2010
83.Total sales of OTC products in Hungary, by product status, 2010
84.Share of OTC products as a proportion of the Hungarian pharmaceutical
market, by value, 2010
85.Value (HUF bn) and y-o-y change in the OTC product market in Hungary,
2008-2013
86.OTC drug market in Hungary, by main product categories (€ m),
2010
87.Market share of main categories of OTC cold products as a proportion of
non-pharmacy sales Hungary, by value, September-December 2009 and 2010
88.Market share of various pharmaceutical forms of OTC cold products as a
proportion of pharmacy and non-pharmacy sales in Hungary, by value,
September-December 2010
89.Average consumer price per package of main categories of OTC cold
products in Hungary (HUF), pharmacy sales, September-December 2009 and 2010
90.Average price per package of selected best-selling analgesics in
Hungary (HUF), H2 2010
91.Most popular groups of dietary supplements used by Bulgarians, 2011
92.Estimate of OTC product market in Bulgaria, by sales channel, 2010
93.OTC pharmacy product market in Bulgaria by product category, by value,
2010
94.OTC pharmacy product market in Bulgaria by product category, by volume,
2010
95.Estimated non-pharmacy sales of OTC products in Bulgaria, by product
status, 2010
96.Estimated total sales of OTC products in Bulgaria, by product status,
2010
97.Estimated share of OTC drugs as a proportion of the Bulgarian
pharmaceutical market, by value, 2010
98.Value (BGN m) and y-o-y change in the OTC product market in Bulgaria,
2009-2013
99.Sales value and volume of dietary supplement pharmacy sales in
Bulgaria, 2009-2010
100.OTC drug market in Bulgaria, by main product categories (€ m),
2010
101.Average price per product package of selected leading OTC
manufacturers in Bulgaria (BGN), 2010
102.Factors which influenced OTC drug purchases in Slovakia, September
2010
103.Share of OTC products as a proportion of the Slovak pharmaceutical
market, by value, 2010
104.Value (€ m) and y-o-y change in the OTC product market in
Slovakia, 2008-2013
105.OTC drug market in Slovakia, by main product categories (€ m),
2010
106.Average price per drug package of selected leading OTC manufacturers
in Slovakia (€ ), 2010 and H1 2011
107.Average price per drug package of selected leading OTC drugs in
Slovakia (€ ), H1 2011
108.Total spending on advertising in Russia ($ m) and y-o-y change,
healthcare and pharmaceuticals, 2008-2010
109.Breakdown of spending on advertising in Russia, by advertising
channel, healthcare and pharmaceuticals, 2008-2010
110.10 leading TV advertisers of OTC drugs and dietary supplements in
Russia, by amount spent, 2010
111.Diod's advertising spending in Russia, by media category, 2007-2010
137
112.Shares of individual media in advertising spending of the
pharmaceutical industry in Poland, H1 2011
113.Spending on TV advertising of the largest advertisers in the
pharmaceutical industry in Poland (PLN m), 2009-H1 2011
114.Spending of pharmaceutical companies on radio advertising in Poland
(PLN m), January-February 2010-2011
115.Spending on outdoor advertising (PLN '000) and change in the
pharmaceutical sector in Poland, 2006-Q1 2011
116.Total spending on drug advertising in Ukraine (UAH m) and y-o-y
change, 2008-January-July 2011
117.Breakdown of spending on drug advertising in Ukraine, by advertising
channel, 2008 - January-July 2011
118.Breakdown of spending on TV drug advertising in Ukraine, by TV
channel, 2010
119.10 leading TV advertisers of OTC drugs in Ukraine, by amount spent,
2010
120.Top 10 brands of OTC drugs in Ukraine in terms of TV advertising
spending, by amount spent, 2010
121.Top 10 OTC products in Ukraine in terms of internet advertising
spending, by amount spent, 2010
122.Top 10 OTC products in Ukraine in terms of internet advertising
spending, by amount spent, Q1 2011
123.Estimated total spending on OTC product advertising in the Czech
Republic (€ m), 2009-H1 2011
124.Advertising spending in the pharmaceutical industry in the Czech
Republic, by medium, 2010
125.Number of drug advertising permits issued by the National Drug Agency
in Romania, 2008-2010
126.Shares of main kinds of advertising as a proportion of the drug
advertising budgets in Romania, 2010
127.Leading TV advertisers of OTC products in Bulgaria (BGN m), by amount
spent, 2009-2010
128.Krka Group organisation chart, 2011
129.Krka global revenues and net profit (€ m), 2006-2011
130.Krka global sales, by region, 2010
131.Krka sales in selected CEE countries (€ m), 2010 and H1 2011
132.Krka global OTC sales, by product groups, 2010 165
133.Gedeon Richter global revenues and net profit (€ m), 2006-H1
2011
134.Gedeon Richter global pharmaceutical sales, by country, 2010
135.Pharmstandard sales revenues and net profit (€ m), 2005-H1 2011
136.Share of OTC products as a proportion of Pharmstandard sales revenues,
2010
137.Top 10 Pharmstandard OTC brands, by value, 2010
138.Sopharma global revenues and net profit (€ m), 2008-H1 2011
139.Sopharma export sales, by country and region, Q3 2010
140.US Pharmacia global sales revenues and net profit (€ m),
2004-2009
141.Walmark global turnover (€ m) and y-o-y change,
2003/2004-2010/2011
142.Walmark turnover (€ m) and y-o-y change in Romania, 2006-2011
143.Market share of top 10 manufacturers of OTC drugs in Russia, by value,
2010
144.Sales value of top 10 manufacturers of dietary supplements in Russia
(€ m), 2010
145.Market share of top 10 manufacturers of dietary supplements in Russia,
by value, 2010
146.Estimated market share of selected top manufacturers of OTC drugs in
Poland, by value, 2010
147.Estimated market share of selected top manufacturers of dietary
supplements in Poland, by value, 2010
148.Market share of top 10 manufacturers of OTC products in Ukraine, by
value, 2010
149.Share of top 10, 25 and 45 companies as a proportion of revenue on the
OTC market in Ukraine, by value, 2009-2010
150.Market share of selected top manufacturers of OTC drugs in Ukraine, by
value, H1 2011
151.Share of OTC drugs and dietary supplements as a proportion of pharmacy
sales value of leading pharmaceutical companies in Ukraine, by value, H1 2011
152.Percentage of OTC and Rx prescriptions in Ukraine, selected
manufacturers, November 2010
153.Estimated market share of selected top manufacturers of OTC drugs in
the Czech Republic, by value, 2010
154.Estimated market share of selected top manufacturers of dietary
supplements in the Czech Republic, by value,
155.Estimated market shares of selected top OTC drug manufacturers in
Hungary, by value, 2010
156.Estimated market shares of selected top dietary supplement
manufacturers in Hungary, by value, 2010
157.Sales value and volume of top 10 manufacturers of OTC drugs and
dietary supplements in Bulgaria, by sales value, 2010
158.Market share of top 10 manufacturers of OTC products in Bulgaria, by
value, 2010
159.Market share of selected top manufacturers of OTC products in
Bulgaria, by volume, 2010
160.Share of OTC products as a proportion of the sales value of
pharmaceutical distributors in Russia, by category of wholesaler, 2010
161.Share of OTC products as a proportion of the sales value of
pharmaceutical distributors in Russia, by category of wholesaler, Q1 2011
162.Concentration of pharmaceutical wholesale in Russia, 2006-2010
163.Market share of largest pharmaceutical wholesalers in Russia, by sales
value, 2010
164.Protek CV revenues ($ bn) and y-o-y change in Russia, 2006-H1 2011
165.Share of parapharmaceuticals as a proportion of Protek CV's gross
profit in Russia, 2010
166.Share of cosmetics and non-drugs as a proportion of Protek CV's
revenues and number of products in Russia, 2010
167.SIA International revenues ($ bn) and y-o-y change in Russia,
2006-2010
168.Katren revenues ($ bn) and y-o-y change in Russia, 2006-2010
169.Rosta revenues ($ bn) and y-o-y change in Russia, 2007-2010
170.Alliance Healthcare revenues ($ m) and y-o-y change in Russia,
2007/2008-2010/2011
171.Share of parapharmaceuticals as a proportion of the sales value of
pharmacy chains in Russia, by category of pharmacy chain, 2010
172.Selected largest pharmacy chains in Russia, by number of outlets,
August 2011
173.Market share of selected largest pharmacy chains as a proportion of
the pharmacy market in Russia, by sales value, 2010
174.Market share of top 10 pharmacy chains in Russia, by sales value,
2003-2010
175.Market share of selected largest pharmacy chains as a proportion of
the pharmacy market in Russia, by sales value, H1 2011
176.36,6 pharmacy chain expansion in Russia (number of units and y-o-y
change), 2003-H1 2011
177.36,6 sales revenues ($ m) and y-o-y change in Russia, 2004-H1 2011
178.Implozia turnover ($ m) and y-o-y change in Russia, 2009-2010
179.Raduga turnover ($ m) and y-o-y change in Russia, 2009-2010
180.Pharmakor sales revenues ($ m) and y-o-y change in Russia, 2009-2010
181.Rigla sales revenues ($ m) and y-o-y change in Russia, 2006-H1 2011
182.Share of OTC drugs and parapharmaceuticals as a proportion of Rigla
sales revenues in Russia, 2010 209
183.A5 net revenues ($ m) and y-o-y change in Russia, 2007-2014
184.Market shares of the largest players on the pharmaceutical wholesale
market in Poland, by sales to pharmacies, H1 2011
185.Neuca group sales revenues (€ m) and y-o-y change in Poland,
2006-H1 2011
186.PGF group sales revenues (€ m) and y-o-y change, 2006-H1 2011
216
187.Farmacol group sales revenues (€ m) and y-o-y change in Poland,
2006-H1 2011
188.ACP Pharma wholesale revenues (€ m) and y-o-y change in Poland,
2006-H1 2011
189.Turnover on the sale of OTC products in individual pharmacy locations
compared to the average pharmacy turnover in Poland (%), 2010
190.Average annual sales of OTC medicines by pharmacies in Poland (PLN
'000): loyalty programme pharmacies, private pharmacies and chain pharmacies,
2009-2010
191.Selected largest pharmacy chains in Poland, by number of outlets,
August 2011
192.ACP Pharma retail sales revenues in Poland (€ m) and y-o-y
change, 2006-H1 2011
193.Revenues and net profit/loss of BRL Center in Poland (€ m),
2004-2009
194.Revenues and net profit/loss of Euro Apteka in Poland (€ m),
2003-2009
195.The most popular online pharmacies in Poland, by number of users (real
users in '000), December 2010
196.Market shares of the largest players on the pharmaceutical wholesale
market in Ukraine, by sales to pharmacies, 2010
197.Concentration of pharmaceutical wholesale in Ukraine, market share by
sales value, H1 2009-H1 2011 229
198.BaDM sales ($ m) and y-o-y change in Ukraine, 2009-2010
199.Optima-Pharm sales ($ m) and y-o-y change in Ukraine, 2009-2010
200.Alba Ukraine sales ($ m) and y-o-y change in Ukraine, 2009-2010
201.VVS sales ($ m) and y-o-y change in Ukraine, 2009-2010 232
202.Fra-M sales ($ m) and y-o-y change in Ukraine, 2009-2010 233
203.Venta sales ($ m) and y-o-y change in Ukraine, 2009-2010 233
204.Share of OTC products as a proportion of Venta's portfolio in Ukraine,
2010
205.Share of OTC products as a proportion of Venta's sales in Ukraine, by
value and volume, 2010
206.Number of pharmacies, pharmacy points and pharmacy kiosks in Ukraine,
January 2002-June 2011
207.Number of pharmacy outlets in Ukraine, by category, June 2011
208.Concentration of pharmacy chains in Ukraine and in particular regions,
market share by sales value, 2010
209.Market share of selected largest pharmacy chains in Ukraine, by sales
value, Q1-Q3 2010
210.Sales revenues of selected largest pharmacy chains in Ukraine (UAH m),
Q1-Q3 2010
211.Selected largest pharmacy chains in Ukraine, by number of outlets,
August 2011
212.Numbers of medicine distribution licence holders in the Czech
Republic, 2004-June 2011
213.Market share of pharmaceutical wholesalers in the Czech Republic, by
value, 2002-2010
214.Phoenix Pharma sales revenues (€ m) and y-o-y change in the
Czech Republic, February 2005-January 2010
215.Alliance Healthcare sales revenues (€ m) and y-o-y change in the
Czech Republic, April 2007-March 2011
216.Share of OTC products as a proportion of Alliance Healthcare revenues
in the Czech Republic, H1 2011
217.Pharmos sales revenues (€ m) and y-o-y change in the Czech
Republic, 2005-2010
218.Gehe Pharma Prague sales revenues (€ m) and y-o-y change in the
Czech Republic, 2006-2010
219.Number of pharmacies and pharmacy points in the Czech Republic,
2000-Q1 2011
220.Selected largest pharmacy chains in the Czech Republic, by number of
outlets, August 2011
221.Ceska lekarna sales revenues (€ m) and y-o-y change in the Czech
Republic, 2007-2009
222.Revenues and gross profit/loss of EuroPharm in the Czech Republic
(€ m), 2006-January 2010
223.Lloyds sales revenues (€ m) and y-o-y change in the Czech
Republic, 2006-2010
224.Number of OTC medicines available at places other than pharmacies in
the Czech Republic, 2004-2009 and February 2011 254
225.Market shares of largest players on the pharmaceutical wholesale
market in Romania, by sales value to pharmacies and hospitals, 2010 256
226.Mediplus sales revenues (€ m) and y-o-y change in Romania,
2003-2010
227.FarmExpert sales revenues (€ m) and y-o-y change in Romania,
2006-2011
228.Fildas Trading revenues (€ m) and y-o-y change in Romania,
2005-2010
229.Polisano sales revenues (€ m) and y-o-y change in Romania,
2002-2010
230.Polisano sales breakdown in Romania, by distribution channel, 2003 and
2009
231.Farmexim sales revenues (€ m) and y-o-y change in Romania,
2006-2011
232.Farmexim net profit (€ m) and y-o-y change in Romania, 2009-2011
233.ADM Farm sales revenues (€ m) and y-o-y change in Romania,
2002-2011
234.Number of pharmacies in Romania, by location, 2010 263
235.Selected largest pharmacy chains in Romania, by number of outlets,
October 2011
236.Sensiblu sales revenues (€ m) and y-o-y change in Romania,
2003-2010
237.Farmaplanet revenue (€ m) and y-o-y change in Romania, 2006-2009
238.Catena sales revenues (€ m) and y-o-y change in Romania,
2007-2010
239.Dona sales revenues (€ m) and y-o-y change in Romania, 2007-2010
268
240.Ropharma sales revenues (€ m) and y-o-y change in Romania,
2007-H1 2011
241.Hermes Pharma revenues (€ m) and y-o-y change in Romania,
2007-2010
242.Help Net sales revenues (€ m) and y-o-y change in Romania,
2002-2011
243.Remedia sales revenues (€ m) and y-o-y change in Romania,
2009-2011
244.Gedeon Richter sales revenues (€ m) and y-o-y change in Romania,
2007-2010
245.Farmacia Richter revenues (€ m) and y-o-y change in Romania,
2007-2010
246.Centrofarm sales revenues (€ m) and y-o-y change in Romania,
2003-H1 2011
247.Estimated market shares of selected largest players on the
pharmaceutical wholesale market in Hungary, by sales to pharmacies and
hospitals, 2010
248.Hungaropharma sales revenues (€ m) and y-o-y change, 2006-2010
249.Phoenix Pharma sales revenues (€ m) and y-o-y change in Hungary,
2006/2007-2010/2011
250.Viridis Pharma sales revenues (€ m) and y-o-y change in Hungary,
2007-2009
251.Number of pharmacy outlets in Hungary, by category, July 2011
252.Selected largest pharmacy chains in Hungary, by number of outlets,
August 2011
253.Pharmacies belonging to Alma pharmacy chain in Hungary, by category,
August 2011
254.Share of OTC products as a proportion of Pingvin Patika revenues in
Hungary, 2010
255.Number of private wholesalers in Bulgaria, 2007-2010
256.Market shares of largest players on the pharmaceutical wholesale
market in Bulgaria, pharmacy and hospital sales, 2010
257.Libra revenues (€ m) and y-o-y change in Bulgaria, 2007-2010
258.Sting revenues (€ m) and y-o-y change in Bulgaria, 2006-2009
259.Sopharma Trading sales revenues and net profit in Bulgaria (€
m), 2007-H1 2011
260.Higia revenues (€ m) and y-o-y change in Bulgaria, 2007-2010
261.Number of private, state-owned and hospital pharmacies in Bulgaria,
2007-2010
262.Average annual turnover of pharmacies in Bulgaria (BGN '000) and y-o-y
change, 2008-2010
263.Selected largest pharmacy chains in Bulgaria, by number of outlets,
August 2011
264.Number of pharmacy outlets operated by SCS Franchise in Bulgaria, by
name, August 2011
265.Market share of pharmaceutical wholesalers in Slovakia, by value,
2008-2010
266.Phoenix Pharma sales revenues (€ m) and y-o-y change in
Slovakia, February 2005-January 2010
267.Unipharma sales revenues (€ m) and y-o-y change in Slovakia,
2004-2009
268.Med-Art sales revenues (€ m) and y-o-y change in Slovakia,
2005-2009
269.Inforama sales revenues (€ m) and y-o-y change in Slovakia,
2004-October 2010
270.Selected largest pharmacy chains in Slovakia, by number of outlets,
August 2011
271.Dr. Max revenues (€ m) and y-o-y change in Slovakia, 2007-2010
272.Comparison of non-pharmacy sales of medicines in CEE countries, 2011
273.Comparison of online sales of medicines in CEE countries, 2011
274.Mean population to pharmacy ratio in selected CEE countries, 2011
275.Countries with the highest GDP growth in the CEE region (%), 2004-2010
276.Countries with the lowest GDP growth in the CEE region (%), 2004-2010
277.Total GDP in CEE countries ($ bn), 2004-2010
278.GDP of CEE countries analysed ($ bn) and its share in total GDP of the
region, 2010
279.Countries with the lowest inflation rates in the CEE region (%),
2004-2010
280.Countries with the highest inflation rates in the CEE region (%),
2004-2010
281.Countries with the lowest unemployment rates in the CEE region (%,
yearly average), 2004-2010
282.Countries with the highest unemployment rates in the CEE region (%,
yearly average), 2004-2010
283.Populations of CEE countries analysed (million of inhabitants), 2010
284.Male life expectancy at birth in CEE countries analysed, 1990 and 2009
285.Female life expectancy at birth in CEE countries analysed, 1990 and
2009
286.Adults of more than 15 years of age who are overweight and obese in
CEE countries analysed (% of population), 2010
287.Incidence of alcohol consumption in CEE in comparison with EU average,
last 12 months, 2009
288.Incidence of alcohol consumption in selected CEE countries, by
country, by incidence, 2009
289.Amount of alcohol drunk in selected CEE countries, by country, by
amount, 2009
290.Incidence of smoking among adults (% of population) in selected CEE
countries, 2009
291.Incidence of smoking among adults (% of population) in selected CEE
countries, by gender, 2009
List of tables
1.Annual average exchange rates used for this report (euro to national
currency), 2006-2010
2.Value and volume of OTC drugs market in Russia, 2010
3.Value and volume of dietary supplements pharmacy market in Russia, 2010
4.Leading OTC drugs and dietary supplements as a proportion of the
out-of-the-pocket plant-based liver protector market in Russia, in terms of
value, Q1-Q3 2010
5.Leading OTC brands by pharmaceutical representative promotions to
pharmacists, 2010
6.Average prices per package and per one tablet of best-selling domestic
OTC headache drugs in Ukraine, Q1 2011
7.Average prices per package and per one tablet of best-selling foreign
OTC headache drugs in Ukraine, Q1 2011
8.Selected best-selling OTC drugs in Ukraine, in terms of value, 2010
9.Selected best-selling OTC drugs in Ukraine, in terms of value, H1 2011
10.Top 10 best-selling OTC domestic headache drugs in Ukraine, in terms of
value, Q1 2011
11.Top 10 best-selling OTC foreign headache drugs in Ukraine, in terms of
value, Q1 2011
12.Top 10 best-selling dietary supplements in Ukraine, pharmacy sales, in
terms of value, 2010
13.Best-selling dietary supplements in individual regions of Ukraine,
pharmacy sales, in terms of value, January-August 2010
14.Top 10 best-selling dietary supplements in Ukraine, pharmacy sales, in
terms of value, H1 2011
15.Changes in medicinal status (Rx to OTC switch) in the Czech Republic,
2010-H1 2011
16.Best-selling OTC products in the Czech Republic, wholesale sales, by
volume, 2010
17.Top two best-selling OTC drugs in Romania, by sales value, Q1 2010 and
Q1 2011
18.Top six best-selling OTC drugs in Romania (million of packages), H1
2011
19.Best selling OTC drugs in Hungary, by value, 2010
20.Best selling OTC analgesics in Hungary, by volume, Q3 2010, Q4 2010 and
January 2011
21.Best selling OTC analgesics in Hungary, by value, Q3 2010, Q4 2010 and
January 2011
22.Average prices of best-selling OTC drugs per package in Bulgaria, 2010
23.Average prices of best-selling dietary supplements per package in
Bulgaria, 2010
24.Top 10 best-selling OTC drugs in Bulgaria, by sales value, 2010
25.Selected best-selling OTC drugs in Bulgaria, by sales volume, 2010
26.Top 10 best-selling dietary supplements in Bulgaria, by sales value,
2010
27.Top 10 best-selling OTC drugs in Slovakia, by value, 2010
28.Top 10 best-selling OTC drugs in Slovakia, by value, H1 2011
29.Top 10 best-selling OTC drugs in Slovakia, by volume, 2010
30.Top 10 best-selling OTC drugs in Slovakia, by volume, H1 2011
31.Leading advertisers of OTC products in the Czech Republic, by amount
spent, H1 2010 and H1 2011
32.Leading advertisers of dietary supplements in the Czech Republic, by
amount spent, 2009-2010
33.10 top brands of OTC drugs in terms of advertising spending in the
Czech Republic, by amount spent, H1 2010 and H1 2011
34.Leading TV advertisers of OTC products in the Czech Republic, by amount
spent, 2009-2010
35.Leading radio advertisers of OTC products in the Czech Republic, by
amount spent, 2009-2010
36.Leading press advertisers of OTC products in the Czech Republic, by
amount spent, 2009-2010
37.Leading outdoor and out-of-home TV advertisers of OTC products in the
Czech Republic, by amount spent, 2009-2010
38.Leading advertisers of OTC brands in Hungary, by amount spent, 2010
39.Leading TV advertisers of OTC brands in Hungary, by amount spent, 2010
40.Data on SUKL activity in the area of drug advertising in Slovakia,
2007-2010
41.Top 10 manufacturers of OTC drugs in Slovakia, by value, 2010
42.Top 10 manufacturers of OTC drugs in Slovakia, by value, H1 2011
191
43.Top 10 manufacturers of OTC drugs in Slovakia, by volume, 2010
44.Top 10 manufacturers of OTC drugs in Slovakia, by volume, H1 2011
45.GDP growth in CEE countries analysed (%), 2004-2010
46.CPI in CEE countries analysed (%), 2004-2010
47.Unemployment rates in CEE countries analysed (%, yearly average),
2004-2010
48.Gross average monthly wages in CEE countries analysed (€ ),
2004-2010 318
OTC market in Central and Eastern Europe 2011 published by PMR in October 30, 2011. This report consists of 341 Pages and the price starts from US $ 3427.
The contents of this page may be different from the latest version. Please contact us for details.
